Understanding the Cardlytics, Inc. Lawsuit: Your Rights and Potential Recovery
On March 6, 2025, in New York, NY, a significant development unfolded regarding Cardlytics, Inc. (NASDAQ: CDLX) and its investors. The Securities and Exchange Commission (SEC) announced that it had filed a complaint against the company, alleging that it made false and misleading statements regarding its financial reporting and business metrics. If you are an affected investor, this article aims to provide you with essential information about the lawsuit and your potential recovery under the federal securities laws.
What Happened with Cardlytics, Inc.?
According to the SEC’s complaint, Cardlytics, Inc. and certain of its executives misstated and failed to disclose material information related to the company’s financial performance and business metrics. Specifically, the SEC alleges that Cardlytics misrepresented the growth trends and financial metrics of its Pulse business segment. This misrepresentation, the SEC claims, continued from at least 2019 through 2021.
Your Rights as an Affected Investor
If you purchased or otherwise acquired Cardlytics, Inc. securities between February 13, 2019, and March 3, 2022, you may be entitled to compensation. The securities laws allow investors to recover damages when companies violate those laws. The deadline to file a claim in the securities class action is approaching. To protect your rights, you should consider submitting a claim form as soon as possible.
How to File a Claim
To submit a claim, follow the link below or contact Joseph E. Levi, Esq., the court-appointed lead plaintiff’s counsel, to discuss your potential recovery:
- Submit a claim form online: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=134430&wire=1
- Contact lead counsel: Joseph E. Levi, Esq., Levi & Korsinsky, LLP, 1001 Brickell Bay Dr. #900, Miami, FL 33131, (305) 476-1000, [email protected]
The Impact on Cardlytics, Inc. and the Investment Community
The Cardlytics, Inc. lawsuit has significant implications for the company and the investment community. The SEC’s allegations, if proven, could result in substantial fines, penalties, and reputational damage for Cardlytics. Moreover, the lawsuit may cause uncertainty and volatility in the stock market, affecting not only Cardlytics but also other companies in the technology sector.
Conclusion
In conclusion, the Cardlytics, Inc. lawsuit marks a crucial moment for the company and its investors. If you are an affected investor, it is essential to understand your rights and potential recovery under the federal securities laws. By filing a claim, you can help hold the company accountable for its alleged misconduct and potentially recover your losses. As the case progresses, we will continue to monitor developments and provide updates on the potential impact on Cardlytics and the investment community.
Stay informed and protect your investments. File your claim today.
Disclaimer: This article is for informational purposes only. It is not a solicitation or an offer to buy or sell any security, and it is not intended to be used for the purpose of making investment decisions, or forming a basis for any investment decision. This article does not constitute investment advice or a recommendation to invest in any securities or other investment vehicles.
